Lyell Immunopharma, Inc. (LYEL)
USD 0.46
(-1.87%)
USD 0.46
(-1.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 130 Thousand | 84.68 Million | 10.65 Million | 7.75 Million | 657 Thousand |
| Cost of Revenue | - | 16.46 Million | 14.53 Million | 7.47 Million | - |
| Gross Profit | 130 Thousand | 68.21 Million | -3.88 Million | 281 Thousand | 657 Thousand |
| Operating Expenses | 247.13 Million | 276.49 Million | 225.42 Million | 219.69 Million | 102.74 Million |
| Selling, General and Administrative Expenses | 66.98 Million | 117.3 Million | 89.05 Million | 46.88 Million | 39.15 Million |
| Research and Development Expenses | 182.94 Million | 159.18 Million | 138.69 Million | 182.24 Million | 63.59 Million |
| Other Expenses | -2.79 Million | 1.88 Million | -2.32 Million | -9.43 Million | -35.4 Million |
| Cost and Expenses | 247.13 Million | 276.49 Million | 225.42 Million | 219.69 Million | 102.74 Million |
| Operating Income | -245.49 Million | -183.11 Million | -214.77 Million | -211.93 Million | -102.08 Million |
| Interest Expense | - | - | - | - | - |
| Income Tax Expense | - | -178.36 Million | 35.28 Million | -5.93 Million | -8.12 Million |
| Earnings before Tax | -234.63 Million | -183.11 Million | -250.21 Million | -204.47 Million | -129.37 Million |
| Net Income | -234.63 Million | -4.75 Million | -285.5 Million | -198.53 Million | -121.25 Million |
| Earnings Per Share Basic | -0.93 | -0.02 | -1.18 | -0.81 | -0.49 |
| Earnings Per Share Diluted | -0.93 | -0.02 | -1.18 | -0.81 | -0.49 |
| Weighted Average Shares Outstanding | 250.98 Million | 247.08 Million | 242.73 Million | 246.57 Million | 246.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 250.98 Million | 247.08 Million | 242.73 Million | 246.57 Million | 246.57 Million |
| Gross Margin | 1.00 | 0.81 | -0.36 | 0.04 | 1.00 |
| EBIT Margin | -1732.68 | -1.95 | -15.47 | -26.77 | -153.47 |
| Profit Margin | -1804.86 | -0.06 | -26.81 | -25.60 | -184.56 |
| EBITDA | -225.24 Million | -166.65 Million | -199.94 Million | -207.64 Million | -100.83 Million |
| Earnings Before Tax Margin | -1888.45 | -2.16 | -20.17 | -27.33 | -155.39 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 13 Thousand | 3000.00 | 13 Thousand | 130 Thousand | 25 Thousand | 27 Thousand |
| Cost of Revenue | 4.9 Million | 5.02 Million | 5.05 Million | 20.25 Million | 5.1 Million | 4.53 Million |
| Gross Profit | -4.88 Million | -5.02 Million | -5.04 Million | -20.12 Million | -5.07 Million | -4.51 Million |
| Operating Expenses | 48.4 Million | 51.11 Million | 54.78 Million | 247.13 Million | 59.06 Million | 65.93 Million |
| Selling, General and Administrative Expenses | 12.25 Million | 13.49 Million | 13.16 Million | - | 15.5 Million | 19.03 Million |
| Research and Development Expenses | 36.15 Million | 37.62 Million | 41.61 Million | - | 43.84 Million | 47.47 Million |
| Other Expenses | -645 Thousand | 1.09 Million | -506 Thousand | 1.84 Million | 1.57 Million | -326 Thousand |
| Cost and Expenses | 53.31 Million | 56.14 Million | 59.84 Million | 247.13 Million | 59.06 Million | 65.93 Million |
| Operating Income | -53.29 Million | -56.14 Million | -59.83 Million | -247 Million | -59.03 Million | -65.9 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | 4.98 Million | 5.01 Million | -10.53 Million | -6.6 Million | -2.34 Million |
| Earnings before Tax | -45.8 Million | -60.66 Million | -52.93 Million | -234.63 Million | -50.85 Million | -63.89 Million |
| Net Income | -45.8 Million | -60.66 Million | -52.93 Million | -234.63 Million | -50.85 Million | -63.89 Million |
| Earnings Per Share Basic | -0.18 | -0.24 | -0.21 | - | -0.20 | -0.26 |
| Earnings Per Share Diluted | -0.18 | -0.24 | -0.21 | - | -0.20 | -0.26 |
| Weighted Average Shares Outstanding | 255.39 Million | 254.25 Million | 253.08 Million | 250.98 Million | 251.31 Million | 250.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 255.39 Million | 254.25 Million | 253.08 Million | 250.98 Million | 251.31 Million | 250.2 Million |
| Gross Margin | -376.00 | -1673.67 | -388.00 | -154.77 | -203.16 | -167.11 |
| EBIT Margin | -3722.77 | -17.03 Thousand | -4213.31 | - | -2157.40 | -2145.19 |
| Profit Margin | -3523.77 | -20.22 Thousand | -4071.54 | -1804.86 | -2034.12 | -2366.30 |
| EBITDA | -48.39 Million | -51.11 Million | -54.77 Million | - | -53.93 Million | -57.92 Million |
| Earnings Before Tax Margin | -4099.77 | -18.71 Thousand | -4602.31 | -1900.06 | -2361.56 | -2440.93 |
FORSE
600685
TTLPF
MLB1
ITMZF
2289